When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...
Eli Lilly and its rivals are working to develop more convenient options than the injectable Zepbound and Wegovy, which ...
The weight-loss succession race is heating up. Here's how biopharma execs talked up those efforts at JPM this week.
The pharmaceutical industry, grappling with new government limits on drug prices, is focusing its requests for ...
While weight loss is a common new year's resolution for workers in the U.S., 2025 may mark the year that building weight loss ...
The governor also said she would work with other states to leverage their combined purchasing power to reduce the cost of the ...
AbbVie closed out the year on a high note, as its blockbuster biologic Skyrizi once again claimed the top spot in 2024’s ...
Hosted on MSN11h
‘Probably going to be the most prescribed drug’; The future of weight loss drugsDrugs like Ozempic, Wegovy and Mounjaro are changing the game for weight loss according to a University of Illinois professor ...
President-elect Donald Trump's HHS appointees represent a broad spectrum of healthcare perspectives and are poised to significantly influence public health, pharmaceuticals and health systems. With ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback